All times are listed in EST (GMT -5).
Discussion (panel)
le 1 février 2021 from 12h45 EDT to 13h30 EDT
Conférenciers / Panélistes
-
Introduction: Where We Are, Where We Have Been, and Where We Are Going
le 1 février 2021 from 11h15 EDT to 12h45 EDT -
Discussion (panel)
le 1 février 2021 from 12h45 EDT to 13h30 EDT -
Introduction: Where We Are, Where We Have Been, and Where We Are Going
le 1 février 2021 from 11h15 EDT to 12h45 EDT -
Discussion (panel)
le 1 février 2021 from 12h45 EDT to 13h30 EDT -
Introduction: Where We Are, Where We Have Been, and Where We Are Going
le 1 février 2021 from 11h15 EDT to 12h45 EDT -
Discussion (panel)
le 1 février 2021 from 12h45 EDT to 13h30 EDT -
Differentiating Between Best Practice and Billing Driven Practice: SBRT in Two Healthcare Systems
le 3 février 2021 from 11h00 EDT to 11h30 EDT -
Discussion (panel)
le 1 février 2021 from 12h45 EDT to 13h30 EDT -
Current State of SBRT Trials (Panel)
le 2 février 2021 from 14h30 EDT to 16h00 EDT -
Introduction: Where We Are, Where We Have Been, and Where We Are Going
le 1 février 2021 from 11h15 EDT to 12h45 EDT -
Discussion (panel)
le 1 février 2021 from 12h45 EDT to 13h30 EDT -
Setting Up SBRT Program
le 4 février 2021 from 11h00 EDT to 12h30 EDT -
Discussion (panel)
le 1 février 2021 from 12h45 EDT to 13h30 EDT
Alanah Bergman, PhD, FCCPM
Medical Physicist
Alanah Bergman, PhD, FCCPM
Alanah Bergman, PhD, FCCPM
Medical Physicist
BSc McGill University, Physics (Hon), 1994
MSc McGill University, Medical Physics, 1997
PhD University of British Columbia, Physics (Medical Physics), 2007
Dr. Bergman is a senior medical physicist at BC Cancer - Vancouver and Fellow of the Canadian College of Physicists in Medicine. She has been in the thick of the rapid expansion of the stereotactic body radiotherapy (SABR) program at BC Cancer. She has seen the program grow from 14 lung SABR patients in 2009 to an extensive multi-site program, treating 300 SABR patients/year including lung, liver, pancreas, spine, bone, adrenal, and lymph node targets. Alanah has been super excited to have BC Cancer participate in several landmark Canadian-led SABR Trials. Her interests currently lie with motion management for lung and liver SABR and she is the lead physicist for the BC Cancer Dynamic Tumour Tracking program. Her current work includes expanding the fiducial-based Liver SABR tracking program and implementing a fiducial-LESS tracking program for Lung and Liver. She is also interested in re-treatment planning workflows, particularly in the SABR context.
Darby Erler, MRT(T), MHSc
Professional Leader
Darby Erler, MRT(T), MHSc
Darby Erler, MRT(T), MHSc
Professional Leader
Professional Leader, Radiation Therapy, Sunnybrook Odette Cancer Centre
Darby Erler MRT(T), MHSc is the Professional Leader for the Radiation Therapy Program at the Sunnybrook Odette Cancer Centre. She is appointed as an Instructor with the Department of Radiation Oncology, University of Toronto and a Practice-Based Researcher at the Sunnybrook Research Institute. Darby completed her degree in Radiation Sciences through the Joint Michener Institute/ University of Toronto Medical Radiation Science program in 2003 and received a Master of Health Science in Medical Radiation Sciences from the University of Toronto in 2015. Prior to taking on the Professional Lead role, she was the Clinical Specialist Radiation Therapist for the Stereotactic Body Radiation Therapy (SBRT) Program for 7 years. Her research interests include assessing clinical outcomes associated with the use of SBRT, evaluating innovations in treatment delivery and improving the patient experience with the use of patient reported outcomes.
Annie Hsu, PhD
Medical Physicist
Annie Hsu, PhD
Annie Hsu, PhD
Medical Physicist
Dr Annie Hsu has been the Associate Head of Medical Physics at the Sunnybrook Odette Cancer Centre since 2019. Prior to this she was a Clinical Associate Professor at Stanford University where she was the Chief of Clinical Physics Radiation Physics Division for five years. She currently serves on the AAPM Clinical Practice Committee, the Spring Clinical Meeting Subcommittee, the Summer School Subcommittee and the Medical Physics Practice Guideline 4.b (TG344). The COMP Winter School Committee is the first COMP activity she has had the pleasure to be involved with. Areas of interest include SBRT and Radiosurgery as well as efficiency in radiation therapy workflows while maintaining safe practices.
Laura Masucci, MD, FRCPC
Radiation Oncologist
Laura Masucci, MD, FRCPC
Laura Masucci, MD, FRCPC
Radiation Oncologist
Dr. Laura Masucci is a radiation oncologist at the Centre Hospitalier de l’Université de Montréal (CHUM). After finishing her radiation oncology residency at the CHUM in 2010, she completed a fellowship at Princess Margaret Hospital specializing in the treatment of primary and secondary brain tumors and radiosurgery of vertebral metastases. She is presently heading the spine SBRT program at the CHUM and is site leader in both CNS oncology and spine SBRT at the department of radiation oncology. She previously served as program director for the radiation oncology residency program at the Université de Montréal. She is now president of the Association of Radiation Oncology of Québec (AROQ).
Devin Schellenberg, MD
Radiation Oncologist
Devin Schellenberg, MD
Devin Schellenberg, MD
Radiation Oncologist
Dr. Devin Schellenberg completed medical school and Residency at the University of BC and University of Toronto. He went onto a Fellowship at Stanford University and is currently the Department Head of Radiation Oncology at the BC Cancer Surrey Centre and the chair of the Lung Radiation Oncology working group with CCTG.
He treats Lung and Gastrointestinal malignancies and is a leader in the Provincial Stereotactic Ablative Body Radiotherapy (SABR) program. His current research efforts focus on how radiation can be used to treat early lung and liver cancers, if radiation can alter the course of metastatic disease, and (outside of cancer) whether radiation is able to treat heart arrhythmias.
Andrea Shessel
MSc, BSc, MRT(T), MRT(MR)
Andrea Shessel
Andrea Shessel
MSc, BSc, MRT(T), MRT(MR)
I’m a radiation therapist in the Radiation Medicine Program at Princess Margaret Cancer Centre since 1991. I received my professional credentials in Radiation Therapy from the PMH School of Radiation Therapy in 1991 and certification in MRI Technology from The Michener Institute in 2002. I received my BSc from the University of Toronto and completed my Master’s Program in Planning at the Sheffield Hallam University in 2020. I am a APRT for Lung and Upper GI sites within our Radiation Medicine Program. My research interests include radiation treatment planning, especially as it relates to target motion.